198 related articles for article (PubMed ID: 2901288)
21. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
22. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
23. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
[TBL] [Abstract][Full Text] [Related]
24. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
Sasaki H; Betensky RA; Cairncross JG; Louis DN
Cancer Res; 2002 Mar; 62(6):1790-6. PubMed ID: 11912156
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
26. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus.
Mori T; Aoki T; Matsubara T; Iida F; Du X; Nishihira T; Mori S; Nakamura Y
Cancer Res; 1994 Apr; 54(7):1638-40. PubMed ID: 7907942
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations associated with glioma progression.
Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
[TBL] [Abstract][Full Text] [Related]
29. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
[TBL] [Abstract][Full Text] [Related]
30. Mitotic recombination of chromosome 17 in astrocytomas.
James CD; Carlbom E; Nordenskjold M; Collins VP; Cavenee WK
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2858-62. PubMed ID: 2565039
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
32. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
33. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.
Reifenberger G; Reifenberger J; Ichimura K; Collins VP
Cancer Res; 1995 Feb; 55(4):731-4. PubMed ID: 7850781
[TBL] [Abstract][Full Text] [Related]
34. Two types of chromosome 1p losses with opposite significance in gliomas.
Idbaih A; Marie Y; Pierron G; Brennetot C; Hoang-Xuan K; Kujas M; Mokhtari K; Sanson M; Lejeune J; Aurias A; Delattre O; Delattre JY
Ann Neurol; 2005 Sep; 58(3):483-7. PubMed ID: 16130103
[TBL] [Abstract][Full Text] [Related]
35. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
37. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.
Balesaria S; Brock C; Bower M; Clark J; Nicholson SK; Lewis P; de Sanctis S; Evans H; Peterson D; Mendoza N; Glaser MG; Newlands ES; Fisher RA
Br J Cancer; 1999 Dec; 81(8):1371-7. PubMed ID: 10604735
[TBL] [Abstract][Full Text] [Related]
38. [Malignant gliomas. Oncogenic considerations].
Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
[TBL] [Abstract][Full Text] [Related]
39. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.
Chernova OB; Somerville RP; Cowell JK
Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of genetic alterations associated with glioma recurrence.
Hulsebos TJ; Oskam NT; Troost D; Leenstra S; Bijleveld EH
Genes Chromosomes Cancer; 1998 Oct; 23(2):153-8. PubMed ID: 9739018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
